Search

CytomX Therapeutics Inc

Slēgts

SektorsVeselības aprūpe

3.73 1.63

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

3.62

Max

3.7800000000000002

Galvenie mērījumi

By Trading Economics

Ienākumi

8.3M

-18M

Pārdošana

9.6M

10M

P/E

Sektora vidējais

22.5

60.549

EPS

-0.1

Peļņas marža

-177.89

Darbinieki

69

EBITDA

9.5M

-18M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+214.63% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 6. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-81M

829M

Iepriekšējā atvēršanas cena

2.1

Iepriekšējā slēgšanas cena

3.73

Ziņu noskaņojums

By Acuity

50%

50%

176 / 342 Rangs Healthcare

CytomX Therapeutics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 13. jūl. 23:41 UTC

Correlated Moves
News
Macro News
ETF Constituents

Vanguard Information Technology ETF declined in after-market hours amid rising crude oil prices and negative sentiment from Oracle's losses, impacting major tech stocks.

2026. g. 13. jūl. 23:26 UTC

News

Shares of Netflix are higher in after-market hours as options traders make bullish bets ahead of the earnings report on July 16.

2026. g. 13. jūl. 23:16 UTC

News

Marriott International will release second-quarter 2026 earnings on August 3, 2026. Shares are higher in after-hours trading, though near the lower end of their range.

2026. g. 13. jūl. 23:11 UTC

News

USD/THB is advancing in Monday's session, supported by a recovery from earlier lows. Rising inflation concerns are influencing market dynamics ahead of upcoming reports.

2026. g. 13. jūl. 23:06 UTC

Social Media
News

Biogen received FDA approval for LEQEMBI IQLIK, a subcutaneous Alzheimer's treatment, boosting shares modestly higher in after-market trading.

2026. g. 13. jūl. 22:51 UTC

News

Vanguard Mortgage-Backed Securities ETF is trading lower in after-market hours, influenced by rising crude oil prices and concerns over inflation and interest rates.

2026. g. 13. jūl. 22:51 UTC

News

The USD/ZAR is trading higher amid geopolitical tensions following U.S. strikes against Iran, maintaining strength near its one-month range.

2026. g. 13. jūl. 22:31 UTC

News
ETF Constituents

Vanguard Growth ETF trades higher in after-market hours, supported by Nvidia and Texas Instruments, amid rising crude oil prices and inflation concerns.

2026. g. 13. jūl. 22:31 UTC

News
Correlated Moves

iShares 7-10 Year Treasury Bond ETF rises slightly after market close, amid rising crude oil prices and inflation concerns influencing broader market volatility.

2026. g. 13. jūl. 22:21 UTC

News

Vanguard Total Bond Market ETF is modestly higher in after-market trading as crude oil prices rise amid escalating U.S.-Iran military tensions.

2026. g. 13. jūl. 22:01 UTC

News

The USD/HUF is gaining, reaching a session high as rising oil prices heighten inflation concerns and potential Federal Reserve interest rate hikes.

2026. g. 13. jūl. 21:51 UTC

Correlated Moves
News

The iShares 20+ Year Treasury Bond ETF is slightly higher in after-market trading as rising U.S. Treasury yields follow President Trump's Iranian blockade announcement.

2026. g. 13. jūl. 20:21 UTC

Correlated Moves
News
ETF Constituents

The Russell 2000 Index is modestly lower after-market, reflecting broader market declines amid U.S.-Iran tensions. Vanguard Small-Cap ETF remains little changed.

2026. g. 13. jūl. 20:07 UTC

Social Media
News

American Airlines Group shares are lower amid concerns over high debt and disappointing revenue passenger miles, despite some optimistic social media discussions.

2026. g. 13. jūl. 20:07 UTC

News
Correlated Moves

Ethereum is trading lower as geopolitical tensions raise inflation concerns and increase market volatility. The cryptocurrency fell from an earlier session high.

2026. g. 13. jūl. 20:07 UTC

Correlated Moves
News

Ethereum is trading lower as geopolitical tensions raise inflation concerns and increase market volatility. The asset remains above its 20-day moving average.

2026. g. 13. jūl. 20:07 UTC

News
Correlated Moves
Social Media

The Polish zloty has weakened, contributing to a modest rise in USD/PLN since Friday's close amid increased military tensions and inflation concerns.

2026. g. 13. jūl. 20:07 UTC

News
Correlated Moves

Silver/NZD declines amid rising inflation concerns linked to surging crude oil prices and fears of interest rate hikes. The asset has closed lower for three sessions.

2026. g. 13. jūl. 20:07 UTC

Correlated Moves
News

Silver is declining amid rising inflation concerns linked to crude oil prices and U.S.-Iran tensions. The asset has pulled back from earlier session gains.

2026. g. 13. jūl. 20:07 UTC

News
Correlated Moves

Silver Ounce vs Euro is declining amid rising inflation concerns linked to crude oil prices and U.S.-Iran tensions, marking three consecutive sessions lower.

2026. g. 13. jūl. 20:07 UTC

Correlated Moves
News

Silver declines amid rising inflation concerns and crude oil price surge. The asset has pulled back from earlier gains, continuing a downward trend.

2026. g. 13. jūl. 20:07 UTC

News
Correlated Moves

Silver declines amid rising inflation concerns linked to crude oil prices. The asset has pulled back from earlier gains and remains below its 20-day moving average.

2026. g. 13. jūl. 20:07 UTC

News
Correlated Moves

USD/CZK is trading higher, supported by broader gains and approaching the upper end of its one-month range amid inflation data and Federal Reserve policy focus.

2026. g. 13. jūl. 20:07 UTC

News
Correlated Moves

The US Dollar Index's rise supports USD/DKK, which is higher since Friday's close. Concerns over U.S.-Iran military actions impact market sentiment.

2026. g. 13. jūl. 20:06 UTC

News

Fiserv shares are higher as leadership changes prompt analysts to monitor potential impacts. The company is also considering the sale of its STAR payment network.

2026. g. 13. jūl. 20:06 UTC

News
Social Media

MercadoLibre opens a new distribution center in Nuevo León, Mexico, creating over 2,000 jobs and enhancing logistics amid rising e-commerce demand. Shares are higher.

2026. g. 13. jūl. 20:06 UTC

News

Gold is trading higher, supported by inflation concerns linked to rising crude oil prices amid U.S.-Iran tensions. Silver has declined after earlier gains.

2026. g. 13. jūl. 20:06 UTC

Correlated Moves
News

The USD/SGD is trading higher, reflecting strength near its one-month range. Broader market dynamics and geopolitical tensions are influencing currency movements.

2026. g. 13. jūl. 20:06 UTC

Correlated Moves
News

The USD/SEK is trading higher, influenced by broader currency market movements and concerns over supply disruptions in the Strait of Hormuz.

2026. g. 13. jūl. 20:06 UTC

News
Correlated Moves

Silver/JPY is declining amid rising inflation concerns linked to crude oil prices and escalating U.S.-Iran tensions. The asset has traded lower for three consecutive sessions.

Salīdzinājums

Cenas izmaiņa

CytomX Therapeutics Inc Prognoze

Cenas mērķis

By TipRanks

214.63% augšup

Prognoze 12 mēnešiem

Vidējais 11.83 USD  214.63%

Augstākais 16 USD

Zemākais 6 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CytomX Therapeutics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

6 ratings

6

Pirkt

0

Turēt

0

Pārdot

Noskaņojums

By Acuity

176 / 342 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par CytomX Therapeutics Inc

CytomX Therapeutics, Inc., an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators, such as cytokines; and PROBODY platform in preclinical research in areas outside of oncology. It also develops CX-904, a T-cell-engaging bispecific antibody targeting the epidermal growth factor receptor (EGFR) on tumor cells and the CD3 receptor on T cells; CX-2051, a conditionally activated ADC for optimizing the therapeutic index for EpCAM-expressing epithelial cancers, including colorectal cancer; and CX-801, an interferon alpha-2b PROBODY cytokine. In addition, the company's development pipeline comprises CX-2029, a conditional activated ADC targeting CD71; and BMS-986288, a PROBODY version of non-fucosylated ipilimumab. It has strategic collaborations with Amgen, Astellas, Bristol Myers Squibb, Regeneron, and Moderna; and clinical trial collaboration and supply agreement with Merck for the evaluation of CX-801 in combination with anti-PD-1 therapy, KEYTRUDA (pembrolizumab). CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.
help-icon Live chat